Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:27 AM UTC
| NCT Number | NCT06887348 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Replimune, Inc. |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of July 19, 2026: Clinical trial NCT06887348 is currently recruiting participants. This clinical trial study for melanoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Replimune, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06887348 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06887348 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.